The impact of uro-oncology multidisciplinary team meetings on patient outcomes and patient engagement in the process

Blake Askelin; Catherine Paterson; Alicia Hind

The impact of uro-oncology multidisciplinary team meetings on patient outcomes and patient engagement in the process

Blake Askelin, Catherine Paterson, Alicia Hind

Research output: Contribution to conference › Abstract › peer-review

Abstract

Cancer multidisciplinary team (MDT) meetings are mainstay management globally. Evidence has identified that within the specialty of uro-oncology not all patients are reviewed by MDTs despite clinical practice guideline recommendations.

Original language	English
Pages	57
Number of pages	1
Publication status	Published - Jul 2021
Externally published	Yes
Event	2021 Canberra Health Annual Research Meeting (CHARM) - Canberra, Australia Duration: 27 Jul 2021 → 30 Jul 2021

Conference

Conference	2021 Canberra Health Annual Research Meeting (CHARM)
Abbreviated title	CHARM
Country/Territory	Australia
City	Canberra
Period	27/07/21 → 30/07/21

Keywords

Multidisciplinary team (MDT)
Patient outcomes
barriers and facilitators

Cite this

@conference{d1b51467451c484b9d284d7e099e2186,

title = "The impact of uro-oncology multidisciplinary team meetings on patient outcomes and patient engagement in the process",

abstract = "Cancer multidisciplinary team (MDT) meetings are mainstay management globally. Evidence has identified that within the specialty of uro-oncology not all patients are reviewed by MDTs despite clinical practice guideline recommendations. ",

keywords = "Multidisciplinary team (MDT), Patient outcomes, barriers and facilitators",

author = "Blake Askelin and Catherine Paterson and Alicia Hind",

year = "2021",

month = jul,

language = "English",

pages = "57",

note = "2021 Canberra Health Annual Research Meeting (CHARM)<br/>, CHARM ; Conference date: 27-07-2021 Through 30-07-2021",

}

TY - CONF

T1 - The impact of uro-oncology multidisciplinary team meetings on patient outcomes and patient engagement in the process

AU - Askelin, Blake

AU - Paterson, Catherine

AU - Hind, Alicia

PY - 2021/7

Y1 - 2021/7

N2 - Cancer multidisciplinary team (MDT) meetings are mainstay management globally. Evidence has identified that within the specialty of uro-oncology not all patients are reviewed by MDTs despite clinical practice guideline recommendations.

AB - Cancer multidisciplinary team (MDT) meetings are mainstay management globally. Evidence has identified that within the specialty of uro-oncology not all patients are reviewed by MDTs despite clinical practice guideline recommendations.

KW - Multidisciplinary team (MDT)

KW - Patient outcomes

KW - barriers and facilitators

UR - https://www.act.gov.au/__data/assets/pdf_file/0006/2291802/Charm-Program-2021.pdf

M3 - Abstract

SP - 57

T2 - 2021 Canberra Health Annual Research Meeting (CHARM)<br/>

Y2 - 27 July 2021 through 30 July 2021

ER -

The impact of uro-oncology multidisciplinary team meetings on patient outcomes and patient engagement in the process

Abstract

Conference

Keywords

Other files and links

Fingerprint

Cite this